Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―

Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Circ Rep
Autores principales: Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika
Formato: Artigo
Lenguaje:Inglês
Publicado: The Japanese Circulation Society 2019
Materias:
Original article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://ncbi.nlm.nih.gov/pubmed/33693148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0034
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares